Jennifer Wesbrook, BS, CTBS
Jennifer has been with AlloSource for 15 years and provides overall management and leadership to the Quality Control, Product Suitability & Release and Quality Management Systems departments. She and her team support the development and implementation of quality improvement initiatives and Design Control (New Product Development) at AlloSource. Under her leadership, AlloSource has developed a robust Quality infrastructure using evidence based best practices to mitigate risk and resolve process deficiencies. Jennifer is AlloSource's Management Representative and acts as liaison with the FDA, ISO, AATB and other regulatory authorities, as well as customers.
Content Where I Am Featured
- Contains 8 Component(s), Includes Credits
The 2020 QDEW is a virtual educational program providing attendees with best practices and new practices in the area of quality, eligibility case studies, and more. This program is designed for physicians who are medical directors or pathologists; those physician specialists (e.g., orthopedic surgeons, burn surgeons) who rely on the use of human tissue in patient care and treatment; nurses; tissue bank specialists; regulatory and quality assurance staff; family donor services staff and others involved in tissue banking.
- Contains 2 Component(s), Includes Credits
Receipt of regulatory audit findings is an opportunity that can serve as a chance to correct issues that have not yet been addressed or revitalize solutions that may have stalled. Regulatory audit findings have the effect of generating a certain degree of focus that should be channeled constructively, and if responded to effectively, can provide freedom from regulatory scrutiny. Strategically approaching regulatory audit responses can help drive improvements to your organization’s inspection readiness protocol and the robustness of your Quality Management System, as well as help clarify operational procedures and processes for future audits.